Biomerica (BMRA) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -11,308.00 |
| Nov 30, 2025 | -9,508.00 |
| Aug 31, 2025 | -9,983.00 |
| May 31, 2025 | -10,935.00 |
| Feb 28, 2025 | 4,026.00 |
| Nov 30, 2024 | 2,132.00 |
| Aug 31, 2024 | 772.00 |
| May 31, 2024 | 363.00 |
| Feb 29, 2024 | -1,797.00 |
| Nov 30, 2023 | -1,298.00 |
| Aug 31, 2023 | -1,258.00 |
| Aug 31, 2022 | -2,787.00 |
| May 31, 2022 | -1,617.00 |
| Feb 28, 2022 | -2,949.00 |
| Nov 30, 2021 | -6,145.00 |
| Aug 31, 2021 | -5,448.00 |
| May 31, 2021 | -4,870.00 |
| Feb 28, 2021 | -2,952.00 |
| Nov 30, 2020 | -2,106.00 |
| Aug 31, 2020 | -1,069.00 |
| May 31, 2020 | 84.00 |
| Feb 29, 2020 | 1,641.00 |
| Nov 30, 2019 | 1,801.00 |
| Aug 31, 2019 | 1,800.00 |
| May 31, 2019 | 2,046.00 |
| Feb 28, 2019 | -4,270.00 |
| Nov 30, 2018 | -3,194.00 |
| Aug 31, 2018 | -3,499.00 |
| Aug 31, 2017 | -3,952.00 |
| May 31, 2017 | -3,040.00 |
| Feb 28, 2017 | -2,720.00 |
| Nov 30, 2016 | -2,443.00 |
| Aug 31, 2016 | -1,556.00 |